1. Home
  2. TMCI vs NEXN Comparison

TMCI vs NEXN Comparison

Compare TMCI & NEXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • NEXN
  • Stock Information
  • Founded
  • TMCI 2014
  • NEXN 2007
  • Country
  • TMCI United States
  • NEXN Israel
  • Employees
  • TMCI N/A
  • NEXN N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NEXN Computer Software: Programming Data Processing
  • Sector
  • TMCI Health Care
  • NEXN Technology
  • Exchange
  • TMCI Nasdaq
  • NEXN Nasdaq
  • Market Cap
  • TMCI 516.6M
  • NEXN 527.2M
  • IPO Year
  • TMCI 2021
  • NEXN 2021
  • Fundamental
  • Price
  • TMCI $6.45
  • NEXN $9.05
  • Analyst Decision
  • TMCI Hold
  • NEXN Strong Buy
  • Analyst Count
  • TMCI 8
  • NEXN 9
  • Target Price
  • TMCI $8.79
  • NEXN $10.63
  • AVG Volume (30 Days)
  • TMCI 365.9K
  • NEXN 401.4K
  • Earning Date
  • TMCI 05-06-2025
  • NEXN 05-19-2025
  • Dividend Yield
  • TMCI N/A
  • NEXN N/A
  • EPS Growth
  • TMCI N/A
  • NEXN N/A
  • EPS
  • TMCI N/A
  • NEXN 0.51
  • Revenue
  • TMCI $209,357,000.00
  • NEXN $365,477,000.00
  • Revenue This Year
  • TMCI $10.85
  • NEXN $5.43
  • Revenue Next Year
  • TMCI $10.07
  • NEXN N/A
  • P/E Ratio
  • TMCI N/A
  • NEXN $17.75
  • Revenue Growth
  • TMCI 11.88
  • NEXN 10.09
  • 52 Week Low
  • TMCI $3.92
  • NEXN $5.41
  • 52 Week High
  • TMCI $11.83
  • NEXN $11.00
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 26.20
  • NEXN 59.79
  • Support Level
  • TMCI $6.39
  • NEXN $6.96
  • Resistance Level
  • TMCI $8.13
  • NEXN $9.10
  • Average True Range (ATR)
  • TMCI 0.56
  • NEXN 0.57
  • MACD
  • TMCI -0.11
  • NEXN 0.15
  • Stochastic Oscillator
  • TMCI 2.77
  • NEXN 97.66

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About NEXN Nexxen International Ltd. American Depository Shares

Nexxen International Ltd empowers advertisers, agencies, publishers, and broadcasters to utilize video and connected TV. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with advanced and exclusive data at its core.

Share on Social Networks: